Source: Investing.com ↗

FDA grants priority review for Enspryng in rare disease MOGAD

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$86,194.46

+1.05%

ETH/USDT

$2,745.26

+0.79%

ZEC/USDT

$1,624.52

+7.43%

XRP/USDT

$1.62

+6.80%